An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B) -inflamed and normal skin.
Phase of Trial: Phase I
Latest Information Update: 10 Jul 2012
At a glance
- Drugs ABT 102; Etoricoxib; Tramadol
- Indications Pain
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.
- 13 Sep 2010 Primary endpoint 'Pain-measures' has been met.